GBM148 GBM Model
GBM148-derived PDX model serves as a cornerstone for understanding the intricacies of Brain Cancer and treatment responses in preclinical drug discovery. Researchers depend on GBM148 PDX to uncover the complexities of the disease, guiding the development of targeted therapies. This model plays a central role in advancing drug development in Brain Cancer, as it enables researchers to fine-tune treatment strategies and optimize outcomes for patients.
Model Details
Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM148
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes
GBM148 Survival
Survival of orthotopic intracranial implanted GBM148 in Nu/Nu mice (n=5)
